Skip to main content
Erschienen in: Supportive Care in Cancer 10/2017

10.06.2017 | Original Article

Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study

verfasst von: Melissa Schorr, Linda E. Carlson, Harold Y. Lau, Lihong Zhong, Barry D. Bultz, Amy Waller, Shannon L. Groff, Desiree Hao

Erschienen in: Supportive Care in Cancer | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Human papillomavirus (HPV)-related cancers have been associated with different demographic profiles and disease characteristics than HPV-unrelated cancers in head and neck patients, but distress and other symptoms have not been compared. The aim of this study was to assess whether distress levels, fatigue, pain, anxiety, depression, and common psychological and practical problems differ between head and neck cancer patients with HPV-related vs. HPV-unrelated carcinomas (using oropharyngeal carcinoma (OPC) and non-OPC cancers as surrogates for HPV status).

Methods

Distress, depression, anxiety, fatigue, pain, and common problems were examined in 56 OPC and 90 non-OPC patients at 4 timepoints during the first year following diagnosis. Two-level hierarchical linear modeling was used to examine effects.

Results

The HPV-related OPC group was more likely to be younger (p = 0.05), Caucasian (p = 0.001), non-smokers (p = 0.01), earn more (p = 0.04), and present with more advanced stage (p < 0.0001). At baseline, OPC patients reported only higher pain scores (p = 0.01) than non-OPC patients. Total problems decreased more in the OPC group (p = 0.08) than the non-OPC group from baseline to 12-month follow-up. In both groups, scores on distress, depression, psychosocial problems, and practical problems decreased similarly over time.

Conclusions

Despite a difference in the clinico-demographic characteristics of HPV-related vs. HPV-unrelated patients, only baseline pain levels and total problems over time differed between the two groups.
Literatur
1.
Zurück zum Zitat Carlson L, Bultz B (2003) Cancer distress screening needs, models and methods. J Psychosom Res 55(5):403–409CrossRefPubMed Carlson L, Bultz B (2003) Cancer distress screening needs, models and methods. J Psychosom Res 55(5):403–409CrossRefPubMed
2.
Zurück zum Zitat Carlson L, Angen M, Callum J, Goodey E, Koopmans J, Lamont L, MacRae J, Martin M, Pelletier G, Robinson J, Simplson J, Speca M, Tillotson L, Bultz B (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90(12):2297–2304PubMedPubMedCentral Carlson L, Angen M, Callum J, Goodey E, Koopmans J, Lamont L, MacRae J, Martin M, Pelletier G, Robinson J, Simplson J, Speca M, Tillotson L, Bultz B (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90(12):2297–2304PubMedPubMedCentral
3.
Zurück zum Zitat Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28CrossRefPubMed Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28CrossRefPubMed
4.
Zurück zum Zitat Holland J, Bultz B (2007) The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Cancer Netw 5(1):3–7CrossRef Holland J, Bultz B (2007) The NCCN guideline for distress management: a case for making distress the sixth vital sign. J Natl Compr Cancer Netw 5(1):3–7CrossRef
5.
Zurück zum Zitat National Comprehensive Cancer Network (2012). Practice guidelines in oncolology-v.2.2012: Distress management National Comprehensive Cancer Network (2012). Practice guidelines in oncolology-v.2.2012: Distress management
6.
Zurück zum Zitat Bultz B, Waller A, Callum J, Jones P, Halland J, Groff S, Leckie C, Shirt L, Blanchard S, Lau H, Easaw J, Fassbender K, Carlson L (2013) Implementing routine screening for distress, the sixth vital sign, for patients with head and neck and neurologic cancers. J Natl Compr Cancer Netw 11(10):1249–1261CrossRef Bultz B, Waller A, Callum J, Jones P, Halland J, Groff S, Leckie C, Shirt L, Blanchard S, Lau H, Easaw J, Fassbender K, Carlson L (2013) Implementing routine screening for distress, the sixth vital sign, for patients with head and neck and neurologic cancers. J Natl Compr Cancer Netw 11(10):1249–1261CrossRef
7.
Zurück zum Zitat Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M (2010) Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population. Cancer 116(11):2635–2644PubMed Auluck A, Hislop G, Bajdik C, Poh C, Zhang L, Rosin M (2010) Trends in oropharyngeal and oral cavity cancer incidence of human papillomavirus (HPV)-related and HPV-unrelated sites in a multicultural population. Cancer 116(11):2635–2644PubMed
8.
Zurück zum Zitat Hocking J, Stein A, Conway E, Regan D, Grulich A, Law M, Brotherton J (2011) Head and neck cancer in Australia between 1982-2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104(5):886–891CrossRefPubMedPubMedCentral Hocking J, Stein A, Conway E, Regan D, Grulich A, Law M, Brotherton J (2011) Head and neck cancer in Australia between 1982-2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 104(5):886–891CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Ryerson A, Peters E, Coughlin S, Chen V, Gillison M, Reichman M, Wu X, Chaturvedi A, Kawaoka K (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 113(10 Suppl):2901–2909CrossRefPubMed Ryerson A, Peters E, Coughlin S, Chen V, Gillison M, Reichman M, Wu X, Chaturvedi A, Kawaoka K (2008) Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003. Cancer 113(10 Suppl):2901–2909CrossRefPubMed
10.
Zurück zum Zitat Chaturvedi A, Engels E, Anderson W, Gillison M (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26(4):612–619CrossRefPubMed Chaturvedi A, Engels E, Anderson W, Gillison M (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26(4):612–619CrossRefPubMed
11.
Zurück zum Zitat Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rakjumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez M, Nieto A, Talamini R, Tavani A, Bosch F, Reidel U, Snijders P, Meijer C, Viscidi R, Munoz N, Franceschi S (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer Multicentre Study. J Natl Cancer Inst 95(23):1772–1783CrossRefPubMed Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rakjumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez M, Nieto A, Talamini R, Tavani A, Bosch F, Reidel U, Snijders P, Meijer C, Viscidi R, Munoz N, Franceschi S (2003) Human papillomavirus and oral cancer: the International Agency for Research on Cancer Multicentre Study. J Natl Cancer Inst 95(23):1772–1783CrossRefPubMed
12.
Zurück zum Zitat Gold D (2012) The psychosocial care needs of patients with HPV-related head and neck cancer. Otolaryngol Clin N Am 45:879–897CrossRef Gold D (2012) The psychosocial care needs of patients with HPV-related head and neck cancer. Otolaryngol Clin N Am 45:879–897CrossRef
13.
Zurück zum Zitat Carlson L, Waller A, Groff S, Zhong L, Bultz B (2012) Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomized controlled trial of computerized vs. personalized triage. Br J Cancer 107(4):617–625. doi:10.1038/bjc.2012.309 CrossRefPubMedPubMedCentral Carlson L, Waller A, Groff S, Zhong L, Bultz B (2012) Online screening for distress, the 6th vital sign, in newly diagnosed oncology outpatients: randomized controlled trial of computerized vs. personalized triage. Br J Cancer 107(4):617–625. doi:10.​1038/​bjc.​2012.​309 CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Carlson L, Waller A, Groff S, Giese-Davis J, Bultz B (2013) What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology 22:168–176CrossRefPubMed Carlson L, Waller A, Groff S, Giese-Davis J, Bultz B (2013) What goes up does not always come down: patterns of distress, physical and psychosocial morbidity in people with cancer over a one year period. Psychooncology 22:168–176CrossRefPubMed
15.
Zurück zum Zitat National Comprehensive Cancer Network Incorporated (2016) Practice guidelines in oncology—v.1.2016. Distress management. National Comprehensive Cancer Network, Inc., Fort Washington National Comprehensive Cancer Network Incorporated (2016) Practice guidelines in oncology—v.1.2016. Distress management. National Comprehensive Cancer Network, Inc., Fort Washington
16.
Zurück zum Zitat National Comprehensive Cancer Network Incorporated (2017) Practice guidelines in oncology—v.2.2017. Cancer-related fatigue. National Comprehensive Cancer Network, Inc., Fort Washington National Comprehensive Cancer Network Incorporated (2017) Practice guidelines in oncology—v.2.2017. Cancer-related fatigue. National Comprehensive Cancer Network, Inc., Fort Washington
17.
Zurück zum Zitat Butt Z, Wagner L, Beaumont J, Paice J, Peterman A, Shevrin D, Von Roenn J, Carro G, Straus J, Muir J, Cella D (2008) Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manag 35(1):20–30CrossRef Butt Z, Wagner L, Beaumont J, Paice J, Peterman A, Shevrin D, Von Roenn J, Carro G, Straus J, Muir J, Cella D (2008) Use of a single-item screening tool to detect clinically significant fatigue, pain, distress, and anorexia in ambulatory cancer practice. J Pain Symptom Manag 35(1):20–30CrossRef
19.
Zurück zum Zitat Linden W, Wodermaier A, McKenzie R, Barroetavena M, Yi D, Doll R (2009) The psychosocial screen for cancer (PSSCAN): further validation and normative data. Health Qual Life Outcomes 7(16):1–8 Linden W, Wodermaier A, McKenzie R, Barroetavena M, Yi D, Doll R (2009) The psychosocial screen for cancer (PSSCAN): further validation and normative data. Health Qual Life Outcomes 7(16):1–8
20.
Zurück zum Zitat Howren M, Christensen A, Karnell L, Van Liew J, Funk G (2012) Influence of pretreatment social support on health-related quality of life in head and neck cancer survivors: results from a prospective study. Head Neck. doi:10.1002/hed.23029 PubMed Howren M, Christensen A, Karnell L, Van Liew J, Funk G (2012) Influence of pretreatment social support on health-related quality of life in head and neck cancer survivors: results from a prospective study. Head Neck. doi:10.​1002/​hed.​23029 PubMed
21.
Zurück zum Zitat Neilson K, Pollard A, Boonzaier A, Corry J, Castle D, Smith D, Trauer T, Couper J (2012) A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer. Psychooncology. doi:10.1002/pon.3228 PubMed Neilson K, Pollard A, Boonzaier A, Corry J, Castle D, Smith D, Trauer T, Couper J (2012) A longitudinal study of distress (depression and anxiety) up to 18 months after radiotherapy for head and neck cancer. Psychooncology. doi:10.​1002/​pon.​3228 PubMed
22.
Zurück zum Zitat Landis S, El-Hariry I, van Herk-Sukel M, van den Haak P, Janssen-Heijnen M, Penning-van Beest F, Herings R (2012) Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck. Head Neck 34(2):238–244CrossRefPubMed Landis S, El-Hariry I, van Herk-Sukel M, van den Haak P, Janssen-Heijnen M, Penning-van Beest F, Herings R (2012) Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck. Head Neck 34(2):238–244CrossRefPubMed
23.
Zurück zum Zitat Sherman A, Simonton S, Adams D, Vural E, Hanna E (2000) Coping with head and neck cancer during different phases of treatment. Head Neck 22(8):787–793CrossRefPubMed Sherman A, Simonton S, Adams D, Vural E, Hanna E (2000) Coping with head and neck cancer during different phases of treatment. Head Neck 22(8):787–793CrossRefPubMed
24.
Zurück zum Zitat de Graeff A, de Leeuw R, Ros W, Hordijk G, Blijham G, Winnubst J (2000) Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 22(4):398–407CrossRefPubMed de Graeff A, de Leeuw R, Ros W, Hordijk G, Blijham G, Winnubst J (2000) Pretreatment factors predicting quality of life after treatment for head and neck cancer. Head Neck 22(4):398–407CrossRefPubMed
25.
26.
Zurück zum Zitat Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S (2012) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck 35(5):747–755CrossRefPubMed Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, Roberts S (2012) Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta-analysis of trends by time and region. Head Neck 35(5):747–755CrossRefPubMed
Metadaten
Titel
Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study
verfasst von
Melissa Schorr
Linda E. Carlson
Harold Y. Lau
Lihong Zhong
Barry D. Bultz
Amy Waller
Shannon L. Groff
Desiree Hao
Publikationsdatum
10.06.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 10/2017
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-017-3733-5

Weitere Artikel der Ausgabe 10/2017

Supportive Care in Cancer 10/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.